Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Centella Asiatica extract - Oneness Biotech

Next Previous
Drug Profile

Centella Asiatica extract - Oneness Biotech

Alternative Names: COMPLEHEAL™; DCB WH1; Fespixon; Fespixon® cream; ON-101; ONENESS™; PA-F4; Plectranthus amboinicus extract - Oneness Biotech; S1; WH 1; Xianglei Tangzu Gao

Latest Information Update: 11 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Development Center for Biotechnology
  • Developer HaiHe Biopharma; Oneness Biotech
  • Class Flavanones; Foot disorder therapies; Herbal medicines; Terpenes
  • Mechanism of Action Macrophage modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Diabetic foot ulcer

Highest Development Phases

  • Marketed Diabetic foot ulcer

Most Recent Events

  • 11 Dec 2025 Launched for Diabetic foot ulcer in Indonesia, Malaysia, Singapore, China (Topical), prior to December 2025 (Oneness Biotech pipeline, December 2025)
  • 11 Dec 2025 Preregistration for Diabetic foot ulcer in Vietnam (Topical),prior to December 2025 (Oneness Biotech pipeline, December 2025)
  • 11 Dec 2025 Registered for Diabetic foot ulcer in Indonesia (Topical), prior to December 2025 (Oneness Biotech pipeline, December 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top